{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:23:08Z","timestamp":1781270588644,"version":"3.54.1"},"reference-count":48,"publisher":"Portland Press Ltd.","issue":"10","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background and aims: Alcoholic fatty liver (AFL) is an early form of alcoholic liver disease (ALD) that usually manifests as lipid synthesis abnormalities in hepatocytes. \u03b2-arrestin2 (Arrb2) is involved in multiple biological processes. The present study aimed to explore the role of Arrb2 in the regulation of lipid metabolism in AFL and the underlying mechanism and identify potential targets for the treatment of AFL. Methods: The expression of Arrb2 was detected in liver tissues obtained from AFL patients and Gao-binge AFL model mice. In addition, we specifically knocked down Arrb2 in AFL mouse liver in vivo and used Arrb2-siRNA or pEX3-Arrb2 to silence or overexpress Arrb2 in AML-12 cells in vitro to explore the functional role and underlying regulatory mechanism of Arrb2 in AFL. Finally, we investigated whether Arrb2 could cause changes in hepatic lipid metabolites, thereby leading to dysregulation of lipid metabolism based on liquid chromatography-mass spectrometry (LC-MS) analysis. Results: Arrb2 was up-regulated in the livers of AFL patients and AFL mice. The in vivo and in vitro results confirmed that Arrb2 could induce lipid accumulation and metabolism disorders. Mechanistically, Arrb2 induced hepatic metabolism disorder via AMP-activated protein kinase (AMPK) pathway. The results of LC-MS analysis revealed that hepatic lipid metabolites with the most significant differences were primary bile acids. Conclusions: Arrb2 induces hepatic lipid metabolism disorders via AMPK pathway in AFL. On one hand, Arrb2 increases fatty acid synthesis. On the other hand, Arrb2 could increase the cholesterol synthesis, thereby leading to the up-regulation of primary bile acid levels.<\/jats:p>","DOI":"10.1042\/cs20201363","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T20:02:30Z","timestamp":1618862550000},"page":"1213-1232","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Arrb2 causes hepatic lipid metabolism disorder via AMPK pathway based on metabolomics in alcoholic fatty liver"],"prefix":"10.1042","volume":"135","author":[{"given":"Ying-Yin","family":"Sun","sequence":"first","affiliation":[{"name":"Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China"},{"name":"The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Medical University, Hefei 230032, China"},{"name":"Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China"},{"name":"Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Qing","family":"Wu","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Na","family":"Yin","sequence":"additional","affiliation":[{"name":"Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China"},{"name":"The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Medical University, Hefei 230032, China"},{"name":"Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[{"name":"Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China"},{"name":"The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Medical University, Hefei 230032, China"},{"name":"Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China"},{"name":"The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Medical University, Hefei 230032, China"},{"name":"Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Di","family":"Li","sequence":"additional","affiliation":[{"name":"Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China"},{"name":"The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Medical University, Hefei 230032, China"},{"name":"Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Li","sequence":"additional","affiliation":[{"name":"Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China"},{"name":"The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Medical University, Hefei 230032, China"},{"name":"Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[{"name":"Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China"},{"name":"The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Medical University, Hefei 230032, China"},{"name":"Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ming","family":"Meng","sequence":"additional","affiliation":[{"name":"Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China"},{"name":"The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Medical University, Hefei 230032, China"},{"name":"Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2605-5697","authenticated-orcid":false,"given":"Hua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-752X","authenticated-orcid":false,"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China"},{"name":"The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Medical University, Hefei 230032, China"},{"name":"Institute for Liver Diseases of Anhui Medical University, Hefei 230032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"2021113011205927700_B1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2468-1253(19)30322-X","article-title":"Restricting alcohol consumption to reduce liver disease in the Asia-Pacific region","volume":"5","author":"Jiang","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2021113011205927700_B2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","author":"Collaborators","year":"2018","journal-title":"Lancet"},{"key":"2021113011205927700_B3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2021113011205927700_B4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/jgh.12030","article-title":"Alcoholic liver disease: pathogenesis, management, and novel targets for therapy","volume":"28","author":"Orman","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2021113011205927700_B5","first-page":"147","article-title":"Alcoholic liver disease: pathogenesis and current management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol. Res."},{"key":"2021113011205927700_B6","doi-asserted-by":"publisher","first-page":"jlr.R119000547","DOI":"10.1194\/jlr.R119000547","article-title":"Alcohol effects on hepatic lipid metabolism","author":"Jeon","year":"2020","journal-title":"J. Lipid Res."},{"key":"2021113011205927700_B7","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.bbalip.2019.04.015","article-title":"Phosphorylation dependent proteostasis of sterol regulatory element binding proteins","volume":"1864","author":"Raghow","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"2021113011205927700_B8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.14218\/JCTH.2017.00061","article-title":"Role of SREBPs in liver diseases: a mini-review","volume":"6","author":"Moslehi","year":"2018","journal-title":"J. Clin. Transl. Hepatol."},{"key":"2021113011205927700_B9","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1074\/jbc.RA119.011849","article-title":"Ring finger protein 5 activates sterol regulatory element-binding protein 2 (SREBP2) to promote cholesterol biosynthesis via ubiquitinating SREBP chaperone SCAP","volume":"295","author":"Kuan","year":"2020","journal-title":"J. Biol. Chem."},{"key":"2021113011205927700_B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.12.004","article-title":"ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation","author":"Zhang","year":"2019","journal-title":"J. Hepatol."},{"key":"2021113011205927700_B11","doi-asserted-by":"publisher","first-page":"11483","DOI":"10.1073\/pnas.1922608117","article-title":"beta-Arrestin2 is a critical component of the GPCR-eNOS signalosome","volume":"117","author":"Liu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011205927700_B12","doi-asserted-by":"publisher","first-page":"E4107","DOI":"10.1073\/pnas.1606267113","article-title":"beta-arrestin-biased signaling through the beta2-adrenergic receptor promotes cardiomyocyte contraction","volume":"113","author":"Carr","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011205927700_B13","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.18632\/aging.202246","article-title":"beta-Arrestin-2 attenuates hepatic ischemia-reperfusion injury by activating PI3K\/Akt signaling","volume":"13","author":"Chen","year":"2020","journal-title":"Aging"},{"key":"2021113011205927700_B14","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/cdd.2016.38","article-title":"beta-Arrestin-2 modulates radiation-induced intestinal crypt progenitor\/stem cell injury","volume":"23","author":"Liu","year":"2016","journal-title":"Cell Death Differ."},{"key":"2021113011205927700_B15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3748\/wjg.v24.i2.216","article-title":"beta-arrestin 2 attenuates lipopolysaccharide-induced liver injury via inhibition of TLR4\/NF-kappaB signaling pathway-mediated inflammation in mice","volume":"24","author":"Jiang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"2021113011205927700_B16","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3389\/fphar.2018.01031","article-title":"beta-Arrestin 2 promotes hepatocyte apoptosis by inhibiting Akt pathway in alcoholic liver disease","volume":"9","author":"Sun","year":"2018","journal-title":"Front. Pharmacol."},{"key":"2021113011205927700_B17","doi-asserted-by":"publisher","first-page":"e12611","DOI":"10.1111\/jpi.12611","article-title":"Melatonin safeguards against fatty liver by antagonizing TRAFs-mediated ASK1 deubiquitination and stabilization in a \u03b2-arrestin-1 dependent manner","volume":"67","author":"Li","year":"2019","journal-title":"J. Pineal Res."},{"key":"2021113011205927700_B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.12.004","article-title":"ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation","author":"Zhang","year":"2019","journal-title":"J. Hepatol."},{"key":"2021113011205927700_B19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bbrc.2013.04.079","article-title":"Loss of \u03b2-arrestin2 mediates pancreatic-islet dysfunction in mice","volume":"435","author":"Zhang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113011205927700_B20","doi-asserted-by":"crossref","DOI":"10.15586\/hepatocellularcarcinoma.2019.ch5","article-title":"The role of lipids in hepatocellular carcinoma","volume-title":"Hepatocellular Carcinoma","author":"Hayes","year":"2019"},{"key":"2021113011205927700_B21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","article-title":"Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease","volume":"144","author":"Svegliati-Baroni","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"2021113011205927700_B22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/iep.12052","article-title":"Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin","volume":"95","author":"Tong","year":"2014","journal-title":"Int. J. Exp. Pathol."},{"key":"2021113011205927700_B23","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1111\/j.1530-0277.2010.01283.x","article-title":"\u00b9H and \u00b3\u00b9P NMR lipidome of ethanol-induced fatty liver","volume":"34","author":"Fernando","year":"2010","journal-title":"Alcohol Clin. Exp. Res."},{"key":"2021113011205927700_B24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"2021113011205927700_B25","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1128\/JVI.73.7.5438-5447.1999","article-title":"Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver","volume":"73","author":"Nakai","year":"1999","journal-title":"J. Virol."},{"key":"2021113011205927700_B26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/jlb.38.2.213","article-title":"Preparation of pure hepatocytes and reticuloendothelial cells in high yield from a single rat liver by means of Percoll centrifugation and selective adherence","volume":"38","author":"Smedsrod","year":"1985","journal-title":"J. Leukoc. Biol."},{"key":"2021113011205927700_B27","doi-asserted-by":"publisher","first-page":"e0190366","DOI":"10.1371\/journal.pone.0190366","article-title":"From in vivo to in vitro: major metabolic alterations take place in hepatocytes during and following isolation","volume":"12","author":"Cassim","year":"2017","journal-title":"PLoS ONE"},{"key":"2021113011205927700_B28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nprot.2013.032","article-title":"Mouse model of chronic and binge ethanol feeding (the NIAAA model)","volume":"8","author":"Bertola","year":"2013","journal-title":"Nat. Protoc."},{"key":"2021113011205927700_B29","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jhep.2017.06.014","article-title":"Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients","volume":"67","author":"Marin","year":"2017","journal-title":"J. Hepatol."},{"key":"2021113011205927700_B30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-59745-242-7_9","article-title":"Human monocytes, macrophages, and dendritic cells: alcohol treatment methods","volume":"447","author":"Szabo","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"2021113011205927700_B31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metab."},{"key":"2021113011205927700_B32","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.bbrc.2019.04.196","article-title":"GSK621 attenuates oxygen glucose deprivation\/re-oxygenation-induced myocardial cell injury via AMPK-dependent signaling","volume":"514","author":"Ting-Ting","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113011205927700_B33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pharmthera.2019.05.006","article-title":"Biased signaling of G protein coupled receptors (GPCRs): molecular determinants of GPCR\/transducer selectivity and therapeutic potential","volume":"200","author":"Seyedabadi","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"2021113011205927700_B34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-4939-9158-7_2","article-title":"\u03b2-Arrestins: multitask scaffolds orchestrating the where and when in cell signalling","volume":"1957","author":"Laporte","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"2021113011205927700_B35","doi-asserted-by":"publisher","first-page":"909","DOI":"10.7150\/ijms.34245","article-title":"Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease","volume":"16","author":"Ogawa","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"2021113011205927700_B36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-1-4939-9158-7_23","article-title":"Methods to investigate \u03b2-arrestin function in metabolic regulation","volume":"1957","author":"Luan","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"2021113011205927700_B37","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1038\/ncomms8369","article-title":"beta-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling","volume":"6","author":"Yang","year":"2015","journal-title":"Nat. Commun."},{"key":"2021113011205927700_B38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ceb.2019.12.007","article-title":"Novel roles of phosphoinositides in signaling, lipid transport, and disease","volume":"63","author":"Hammond","year":"2020","journal-title":"Curr. Opin. Cell Biol."},{"key":"2021113011205927700_B39","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.3390\/ijms19113473","article-title":"Involvement of 5'-activated protein kinase (AMPK) in the effects of resveratrol on liver steatosis","volume":"19","author":"Trepiana","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"2021113011205927700_B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2015.12.022","article-title":"Betulin alleviated ethanol-induced alcoholic liver injury via SIRT1\/AMPK signaling pathway","volume":"105","author":"Bai","year":"2016","journal-title":"Pharmacol. Res."},{"key":"2021113011205927700_B41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2091-11-36","article-title":"Beta-arrestin inhibits CAMKKbeta-dependent AMPK activation downstream of protease-activated-receptor-2","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Biochem."},{"key":"2021113011205927700_B42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bcp.2015.06.036","article-title":"Altered energy state reversibly controls smooth muscle contractile function in human saphenous vein during acute hypoxia-reoxygenation: role of glycogen, AMP-activated protein kinase, and insulin-independent glucose uptake","volume":"97","author":"Pyla","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"2021113011205927700_B43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"2021113011205927700_B44","doi-asserted-by":"publisher","first-page":"27855","DOI":"10.1074\/jbc.R111.254359","article-title":"Many ceramides","volume":"286","author":"Hannun","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2021113011205927700_B45","doi-asserted-by":"publisher","first-page":"G1004","DOI":"10.1152\/ajpgi.00482.2009","article-title":"Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levels","volume":"298","author":"Liangpunsakul","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2021113011205927700_B46","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cmet.2006.03.007","article-title":"The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis","volume":"3","author":"Li","year":"2006","journal-title":"Cell Metab."},{"key":"2021113011205927700_B47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fmed.2020.00015","article-title":"Bile acid receptor therapeutics effects on chronic liver diseases","volume":"7","author":"Meadows","year":"2020","journal-title":"Front. Med."},{"key":"2021113011205927700_B48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.tiv.2019.06.002","article-title":"Bile salts regulate CYP7A1 expression and elicit a fibrotic response and abnormal lipid production in 3D liver microtissues","volume":"60","author":"Messner","year":"2019","journal-title":"Toxicol. In Vitro"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/10\/1213\/911898\/cs-2020-1363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/10\/1213\/911898\/cs-2020-1363.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:17:52Z","timestamp":1638274672000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/135\/10\/1213\/228413\/Arrb2-causes-hepatic-lipid-metabolism-disorder-via"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,5,28]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20201363","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5]]},"published":{"date-parts":[[2021,5]]}}}